THE ROLE of DYSTONIN and Macfl in SKELETAL MUSCLE By

Total Page:16

File Type:pdf, Size:1020Kb

THE ROLE of DYSTONIN and Macfl in SKELETAL MUSCLE By THE ROLE OF DYSTONIN AND MACFl IN SKELETAL MUSCLE by: SOPHIE JOANISSE A thesis submitted as a partial fulfillment of the requirement for the degree of Maitrise en activite physique (M.A.P) School of Graduate Studies Laurentian University Sudbury, Ontario © Sophie Joanisse, 2011 Library and Archives Bibliotheque et 1*1 Canada Archives Canada Published Heritage Direction du Branch Patrimoine de I'edition 395 Wellington Street 395, rue Wellington OttawaONK1A0N4 Ottawa ON K1A 0N4 Canada Canada Your file Votre r6ference ISBN: 978-0-494-82027-8 Our file Notre r&terence ISBN: 978-0-494-82027-8 NOTICE: AVIS: The author has granted a non­ L'auteur a accorde une licence non exclusive exclusive license allowing Library and permettant a la Bibliotheque et Archives Archives Canada to reproduce, Canada de reproduire, publier, archiver, publish, archive, preserve, conserve, sauvegarder, conserver, transmettre au public communicate to the public by par telecommunication ou par I'lnternet, preter, telecommunication or on the Internet, distribuer et vendre des theses partout dans le loan, distribute and sell theses monde, a des fins commerciales ou autres, sur worldwide, for commercial or non­ support microforme, papier, electronique et/ou commercial purposes, in microform, autres formats. paper, electronic and/or any other formats. The author retains copyright L'auteur conserve la propriete du droit d'auteur ownership and moral rights in this et des droits moraux qui protege cette these. Ni thesis. Neither the thesis nor la these ni des extraits substantiels de celle-ci substantial extracts from it may be ne doivent etre imprimes ou autrement printed or otherwise reproduced reproduits sans son autorisation. without the author's permission. In compliance with the Canadian Conformement a la loi canadienne sur la Privacy Act some supporting forms protection de la vie privee, quelques may have been removed from this formulaires secondaires ont ete enleves de thesis. cette these. While these forms may be included Bien que ces formulaires aient inclus dans in the document page count, their la pagination, il n'y aura aucun contenu removal does not represent any loss manquant. of content from the thesis. 1*1 Canada iii Abstract Dystonin and microtubule actin cross linking factor 1 (MACF 1) are crosslinking proteins that are members of the plakin family. Plakin crosslinking proteins are believed to play a crucial role in maintaining the structural and mechanical integrity of contractile cells. The specific functions of dystonin and MACFl in skeletal muscle are not yet thoroughly understood. To gain further insights into the role of dystonin and MACFl in contractile cells, the subcellular localization of these plakin proteins in longitudinal sections of mouse hindlimb skeletal muscle was determined by double immunofluorescence experiments. Furthermore, the impact of dystonin-deficiency on specific cytoskeletal networks was assessed. The localization of dystonin and MACFl was compared to that of other proteins that localize to specific compartments of the muscle fiber namely the sarcomere (myosin/actin), the Z-disc (a-actinin/desmin), the subsarcolemmal area (desmin) and the neuromuscular junction (rapsyn/acetylcholine resceptors). In parallel, the expression profile of dystonin and MACFl in type I (slow-twitch) and type II (fast-twitch) fibers was assessed by immunofluorescence. The expression of dystonin and MACFl was also determined in soleus and gastrocnemius muscle by Western blot. In longitudinal sections and single muscle fibers of hindlimb muscle immunofluorescence staining of both dystonin and MACFl were observed at the Z-disc. Dystonin staining was also present at the subsarcolemmal area and at the perinuclear region while MACFl staining was present at the neuromuscular junction. iv Serial cross-sections of muscle fibers from mouse soleus and gastrocnemius muscles were stained for type I myosin heavy chain (labelling slow-twitch fibers) and either dystonin or MACFl. These immunofluorescence experiments revealed no difference in staining intensity for both dystonin and MACFl in either fast- or slow- twitch fibers. Howevere, dystonin and MACFl protein levels were significantly higher (1.5- and 2-fold respectively) in fast-twitch gastrocnemius muscle versus slow-twitch soleus muscle as revealed by Western blotting. Taken together these experiments suggest that dystonin and MACFl are more highly expressed in predominantly fast-twitch muscle. The protein expression profile of MACFl, plectin and cytoskeletal proteins actin, a-tubulin, desmin and a-actinin were compared between hindlimb skeletal muscles excised from dystonin-deficient (dt) and wild-type (wt) mice from the dystonia musculorum Tg4 (dt g ) transgenic mouse line. The results suggest that while the microfilament and microtubule network appears to be largely unaffected in dystonin- deficient muscle, the expression levels of the intermediate filament desmin is down- regulated in skeletal muscle of dt mice whereas the levels of a-actinin, MACFl and plectin are up-regulated. Collectively, our findings suggest that dystonin and MACFl exert their respective functions in specific subcellular compartments of the muscle fiber based on our localization studies and that predominantly fast-twitch fibers express greater levels of these crosslinking proteins. When skeletal muscles lack dystonin the other muscle plakins (MACFl and plectin) appear to undergo a compensatory up-regulation that is likely V sufficient to stabilize the microtubule and microfilament networks but not the desmin or a-actinin cytoarchitecture. vi Acknowledgements First I would like to extend my sincere gratitude to my supervisor Dr. Boudreau-Lariviere for her direction, assistance and guidance from the preliminary to the concluding stages of the project. Dr. Boudreau-Lariviere has given me the opportunity to advance my knowledge and skill as a researcher and enabled me to develop a thorough understanding of the subject. I am also greatful to all lab co-workers in particular Tyler Kirwan for his help, insight and technical assistance, Paul Micheal for his advice, as well as as my committee members Drs. Dorman and Ritz for their helpful suggestions and comments. Additionally, I would like to acknowledge Chris Blomme and Nicole Paquette for ensuring the proper care of all mice used during the course of the study. Lastly, I would like to thank my family for their constant support and encouragement during these past years. vii List of abbreviations ABD; Actin binding domain ACF7; Actin crosslinking factor 7 ACh; Acetylcholine AChRs; Acetylcholine receptors ACTA1; a-skeletal actin gene ACTC; a-cardiac actin gene Bpagl; Bullous pemphigoid antigen 1 CH; Calponin homology CRP; Cysteine-rich protein DCM; Dilated cardiomyopathy DRM; Desmin-related myopathies dt; Dystonia musculorum dtTg4; Dystonia musculorum transgenic line 4 (insertional mutation) EBS-MD; Epidermolysis bullosa simplex-with muscular dystrophy ECM; Extracellular matrix FATZ; Filamin-, a-actinin- and telethonin-binding protein of the Z-disc viii GAR; Gas2-related GAS; Gastrocnemius muscle GSR; Glycine-serine-arginine rich HCM; Hypertrophic cardiomyopathy IF; Intermediate filaments IFBD; Intermediate filament binding domain IFBD2; Intermediate filament binding domain of the dystonin-b muscle isoform IHC; Immunohistochemical MACFl; Microtubule actin cross-linking factor 1 mATPase; Myofibrillar actomyosin adenosine triphosphatase MD; Muscular dystrophy MF; Microfilaments MHC; Myosin heavy chain MT; Microtubules MTBD; Microtubule binding domain NMJ; Neuromuscular junction PCR; Polymerase chain reaction ix PLECl; Human plectin gene PRD; Plakin repeat domain SOL; Soleus muscle SR-rods; Spectrin repeat rods wt; Wild-type X Table of Contents Abstract iii Acknowledgments vi List of abbreviations vii Table of contents x List of Figures xii CHAPTER 1: Introduction 1 1.0 Introduction 1 2.0 Basic structure of the skeletal muscle fiber 3 2.1 TheZ-disc 4 2.2 The Costamere 4 2.3 The Neuromuscular Junction 6 3.0 Slow- and fast-twitch muscle fibers 7 4.0 Involvement of cytoskeletal proteins in myopathies 9 5.0 The Cvtoskeleton 11 5.1 Microfilaments 11 5.2 Intermediate filaments 12 5.3 Microtubules 14 6.0 Plakin family of cross-linking proteins 15 6.1 Plakins in skeletal muscle 16 6.2 Plectin gene and plectin muscle isoforms 17 6.2.1 Plectin and disease 18 6.3 Dystonin 19 6.3.1 Dystonin gene 20 6.3.2 Dystonin isoforms 20 6.3.3 Dystonia musculorum (dt) mice 24 6.3.4 Abnormalities in dt g striated muscle 25 6.3.5 Dystonin and disease 26 6.4MACF1 28 6.4.1 MACF1 gene 28 6.4.2 MACF1 isoforms 29 xi 6.4.3 MACF1 and disease 30 7.0 Statement of the problem 31 8.0 Specific hypotheses 32 References 33 CHAPTER 2: Manuscript 47 Abstract 48 Introduction 50 Materials and Methods 53 Results 57 Discussion 74 References 82 CHAPTER 3: General discussion 88 1.0 Plakin protein localization in skeletal muscle fibers 88 2.0 Protein expression profile of plakin proteins in slow-twitch versus fast-twitch muscle fibers 93 3.0 Cytoskeletal protein alterations in dystonin-deficient skeletal muscle 94 4.0 Conclusion 96 References 97 XII List of Figures Figure 1.1 Schematic representation of the cytoskeleton 2 Figure 1.2 Schematic representation of the skeletal muscle fiber 5 Figure 1.3 Schematic representation of protein structure of plakin proteins 17 Figure 1.4 Schematic representation of the three alternatively spliced dystonin iso forms 24 Figure 2.1 Localization of dystonin-b in skeletal muscle relative to desmin,
Recommended publications
  • The Spectraplakin Dystonin Antagonizes YAP Activity and Suppresses Tumourigenesis Praachi B
    www.nature.com/scientificreports OPEN The spectraplakin Dystonin antagonizes YAP activity and suppresses tumourigenesis Praachi B. Jain1,2,3, Patrícia S. Guerreiro1,2,3, Sara Canato1,2,3 & Florence Janody 1,2,3* Aberrant expression of the Spectraplakin Dystonin (DST) has been observed in various cancers, including those of the breast. However, little is known about its role in carcinogenesis. In this report, we demonstrate that Dystonin is a candidate tumour suppressor in breast cancer and provide an underlying molecular mechanism. We show that in MCF10A cells, Dystonin is necessary to restrain cell growth, anchorage-independent growth, self-renewal properties and resistance to doxorubicin. Strikingly, while Dystonin maintains focal adhesion integrity, promotes cell spreading and cell-substratum adhesion, it prevents Zyxin accumulation, stabilizes LATS and restricts YAP activation. Moreover, treating DST- depleted MCF10A cells with the YAP inhibitor Verteporfn prevents their growth. In vivo, the Drosophila Dystonin Short stop also restricts tissue growth by limiting Yorkie activity. As the two Dystonin isoforms BPAG1eA and BPAG1e are necessary to inhibit the acquisition of transformed features and are both downregulated in breast tumour samples and in MCF10A cells with conditional induction of the Src proto-oncogene, they could function as the predominant Dystonin tumour suppressor variants in breast epithelial cells. Thus, their loss could deem as promising prognostic biomarkers for breast cancer. Breast cancer progression depends on cell autonomous regulatory mechanisms, driven by mutations and epi- genetic changes, and on non-cell autonomous interactions with the surrounding tumour microenvironment1,2. During this multistep process, normal breast epithelial cells acquire various cellular properties arising from dereg- ulated cellular signalling3,4.
    [Show full text]
  • Drp1 Overexpression Induces Desmin Disassembling and Drives Kinesin-1 Activation Promoting Mitochondrial Trafficking in Skeletal Muscle
    Cell Death & Differentiation (2020) 27:2383–2401 https://doi.org/10.1038/s41418-020-0510-7 ARTICLE Drp1 overexpression induces desmin disassembling and drives kinesin-1 activation promoting mitochondrial trafficking in skeletal muscle 1 1 2 2 2 3 Matteo Giovarelli ● Silvia Zecchini ● Emanuele Martini ● Massimiliano Garrè ● Sara Barozzi ● Michela Ripolone ● 3 1 4 1 5 Laura Napoli ● Marco Coazzoli ● Chiara Vantaggiato ● Paulina Roux-Biejat ● Davide Cervia ● 1 1 2 1,4 6 Claudia Moscheni ● Cristiana Perrotta ● Dario Parazzoli ● Emilio Clementi ● Clara De Palma Received: 1 August 2019 / Revised: 13 December 2019 / Accepted: 23 January 2020 / Published online: 10 February 2020 © The Author(s) 2020. This article is published with open access Abstract Mitochondria change distribution across cells following a variety of pathophysiological stimuli. The mechanisms presiding over this redistribution are yet undefined. In a murine model overexpressing Drp1 specifically in skeletal muscle, we find marked mitochondria repositioning in muscle fibres and we demonstrate that Drp1 is involved in this process. Drp1 binds KLC1 and enhances microtubule-dependent transport of mitochondria. Drp1-KLC1 coupling triggers the displacement of KIF5B from 1234567890();,: 1234567890();,: kinesin-1 complex increasing its binding to microtubule tracks and mitochondrial transport. High levels of Drp1 exacerbate this mechanism leading to the repositioning of mitochondria closer to nuclei. The reduction of Drp1 levels decreases kinesin-1 activation and induces the partial recovery of mitochondrial distribution. Drp1 overexpression is also associated with higher cyclin-dependent kinase-1 (Cdk-1) activation that promotes the persistent phosphorylation of desmin at Ser-31 and its disassembling. Fission inhibition has a positive effect on desmin Ser-31 phosphorylation, regardless of Cdk-1 activation, suggesting that induction of both fission and Cdk-1 are required for desmin collapse.
    [Show full text]
  • Gene Expression Signatures and Biomarkers of Noninvasive And
    Oncogene (2006) 25, 2328–2338 & 2006 Nature Publishing Group All rights reserved 0950-9232/06 $30.00 www.nature.com/onc ORIGINAL ARTICLE Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics GM Nagaraja1, M Othman2, BP Fox1, R Alsaber1, CM Pellegrino3, Y Zeng2, R Khanna2, P Tamburini3, A Swaroop2 and RP Kandpal1 1Department of Biological Sciences, Fordham University, Bronx, NY, USA; 2Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA and 3Bayer Corporation, West Haven, CT, USA We have characterized comprehensive transcript and Keywords: representational difference analysis; micro- proteomic profiles of cell lines corresponding to normal arrays; proteomics; breast carcinoma; biomarkers; breast (MCF10A), noninvasive breast cancer (MCF7) and copper homeostasis invasive breast cancer (MDA-MB-231). The transcript profiles were first analysed by a modified protocol for representational difference analysis (RDA) of cDNAs between MCF7 and MDA-MB-231 cells. The majority of genes identified by RDA showed nearly complete con- Introduction cordance withmicroarray results, and also led to the identification of some differentially expressed genes such The transformation of a normal cell into a cancer cell as lysyl oxidase, copper transporter ATP7A, EphB6, has been correlated to altered expression of a variety of RUNX2 and a variant of RUNX2. The altered transcripts genes (Perou et al., 2000; Becker et al., 2005). The identified by microarray analysis were involved in cell–cell expression of some of these genes is a direct result of or cell–matrix interaction, Rho signaling, calcium home- sequence mutation, whereas other changes occur due to ostasis and copper-binding/sensitive activities.
    [Show full text]
  • Supplementary Table 1 Genes Tested in Qrt-PCR in Nfpas
    Supplementary Table 1 Genes tested in qRT-PCR in NFPAs Gene Bank accession Gene Description number ABI assay ID a disintegrin-like and metalloprotease with thrombospondin type 1 motif 7 ADAMTS7 NM_014272.3 Hs00276223_m1 Rho guanine nucleotide exchange factor (GEF) 3 ARHGEF3 NM_019555.1 Hs00219609_m1 BCL2-associated X protein BAX NM_004324 House design Bcl-2 binding component 3 BBC3 NM_014417.2 Hs00248075_m1 B-cell CLL/lymphoma 2 BCL2 NM_000633 House design Bone morphogenetic protein 7 BMP7 NM_001719.1 Hs00233476_m1 CCAAT/enhancer binding protein (C/EBP), alpha CEBPA NM_004364.2 Hs00269972_s1 coxsackie virus and adenovirus receptor CXADR NM_001338.3 Hs00154661_m1 Homo sapiens Dicer1, Dcr-1 homolog (Drosophila) (DICER1) DICER1 NM_177438.1 Hs00229023_m1 Homo sapiens dystonin DST NM_015548.2 Hs00156137_m1 fms-related tyrosine kinase 3 FLT3 NM_004119.1 Hs00174690_m1 glutamate receptor, ionotropic, N-methyl D-aspartate 1 GRIN1 NM_000832.4 Hs00609557_m1 high-mobility group box 1 HMGB1 NM_002128.3 Hs01923466_g1 heterogeneous nuclear ribonucleoprotein U HNRPU NM_004501.3 Hs00244919_m1 insulin-like growth factor binding protein 5 IGFBP5 NM_000599.2 Hs00181213_m1 latent transforming growth factor beta binding protein 4 LTBP4 NM_001042544.1 Hs00186025_m1 microtubule-associated protein 1 light chain 3 beta MAP1LC3B NM_022818.3 Hs00797944_s1 matrix metallopeptidase 17 MMP17 NM_016155.4 Hs01108847_m1 myosin VA MYO5A NM_000259.1 Hs00165309_m1 Homo sapiens nuclear factor (erythroid-derived 2)-like 1 NFE2L1 NM_003204.1 Hs00231457_m1 oxoglutarate (alpha-ketoglutarate)
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • Hearts of Dystonia Musculorum Mice Display Normal Morphological and Histological Features but Show Signs of Cardiac Stress
    Hearts of Dystonia musculorum Mice Display Normal Morphological and Histological Features but Show Signs of Cardiac Stress Justin G. Boyer2,4,5., Kunal Bhanot4,5., Rashmi Kothary4,5,Ce´line Boudreau-Larivie`re1,2,3* 1 School of Human Kinetics, Laurentian University, Sudbury, Ontario, Canada, 2 Department of Biology, Laurentian University, Sudbury, Ontario, Canada, 3 Biomolecular Sciences Program, Laurentian University, Sudbury, Ontario, Canada, 4 Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, 5 Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada Abstract Dystonin is a giant cytoskeletal protein belonging to the plakin protein family and is believed to crosslink the major filament systems in contractile cells. Previous work has demonstrated skeletal muscle defects in dystonin-deficient dystonia musculorum (dt) mice. In this study, we show that the dystonin muscle isoform is localized at the Z-disc, the H zone, the sarcolemma and intercalated discs in cardiac tissue. Based on this localization pattern, we tested whether dystonin- deficiency leads to structural defects in cardiac muscle. Desmin intermediate filament, microfilament, and microtubule subcellular organization appeared normal in dt hearts. Nevertheless, increased transcript levels of atrial natriuretic factor (ANF, 66%) b-myosin heavy chain (beta-MHC, 95%) and decreased levels of sarcoplasmic reticulum calcium pump isoform 2A (SERCA2a, 26%), all signs of cardiac muscle stress, were noted in dt hearts. Hearts from two-week old dt mice were assessed for the presence of morphological and histological alterations. Heart to body weight ratios as well as left ventricular wall thickness and left chamber volume measurements were similar between dt and wild-type control mice.
    [Show full text]
  • Basal Cells As Stem Cells of the Mouse Trachea and Human Airway Epithelium
    Basal cells as stem cells of the mouse trachea and human airway epithelium Jason R. Rocka, Mark W. Onaitisb, Emma L. Rawlinsa, Yun Lua, Cheryl P. Clarka, Yan Xuea, Scott H. Randellc, and Brigid L. M. Hogana,1 Departments of aCell Biology and bSurgery, Duke University Medical Center, Durham, NC 27710; and cCystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina, Chapel Hill, NC 27559 Contributed by Brigid L. M. Hogan, June 18, 2009 (sent for review May 16, 2009) The pseudostratified epithelium of the mouse trachea and human Results and Discussion airways contains a population of basal cells expressing Trp-63 (p63) In Vivo Lineage Tracing of Mouse Tracheal BCs. Previous lineage T2 and cytokeratins 5 (Krt5) and Krt14. Using a KRT5-CreER trans- tracing of mouse tracheal BCs after injury used a KRT14-CreER genic mouse line for lineage tracing, we show that basal cells transgene (8). However, this allele is inefficient for labeling BCs generate differentiated cells during postnatal growth and in the in steady state. We therefore made a new line in which a 6-kb adult during both steady state and epithelial repair. We have human keratin 5 (KRT5) promoter drives CreERT2 (Fig. 1A). We fractionated mouse basal cells by FACS and identified 627 genes used this allele, in combination with the Rosa26R-lacZ reporter, preferentially expressed in a basal subpopulation vs. non-BCs. to lineage trace BCs in adult mice for up to 14 weeks (Fig. 1B). Analysis reveals potential mechanisms regulating basal cells and Soon after the last tamoxifen (Tmx) injection, most of the allows comparison with other epithelial stem cells.
    [Show full text]
  • Analysis of Gene Expression in Human Dermal Fibroblasts Treated with Senescence-Modulating COX Inhibitors
    eISSN 2234-0742 Genomics Inform 2017;15(2):56-64 G&I Genomics & Informatics https://doi.org/10.5808/GI.2017.15.2.56 ORIGINAL ARTICLE Analysis of Gene Expression in Human Dermal Fibroblasts Treated with Senescence-Modulating COX Inhibitors Jeong A. Han1*, Jong-Il Kim2,3,4** 1Department of Biochemistry and Molecular Biology, Kangwon National University School of Medicine, Chuncheon 24341, Korea, 2Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul 03080, Korea, 3Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Korea, 4Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea We have previously reported that NS-398, a cyclooxygenase-2 (COX-2)–selective inhibitor, inhibited replicative cellular senescence in human dermal fibroblasts and skin aging in hairless mice. In contrast, celecoxib, another COX-2–selective inhibitor, and aspirin, a non-selective COX inhibitor, accelerated the senescence and aging. To figure out causal factors for the senescence-modulating effect of the inhibitors, we here performed cDNA microarray experiment and subsequent Gene Set Enrichment Analysis. The data showed that several senescence-related gene sets were regulated by the inhibitor treatment. NS-398 up-regulated gene sets involved in the tumor necrosis factor β receptor pathway and the fructose and mannose metabolism, whereas it down-regulated a gene set involved in protein secretion. Celecoxib up-regulated gene sets involved in G2M checkpoint and E2F targets. Aspirin up-regulated the gene set involved in protein secretion, and down-regulated gene sets involved in RNA transcription. These results suggest that COX inhibitors modulate cellular senescence by different mechanisms and will provide useful information to understand senescence-modulating mechanisms of COX inhibitors.
    [Show full text]
  • Restoration of Desmosomal Junction Protein Expression and Inhibition Of
    MOLECULAR AND CLINICAL ONCOLOGY 3: 171-178, 2015 Restoration of desmosomal junction protein expression and inhibition of H3K9‑specifichistone demethylase activity by cytostatic proline‑rich polypeptide‑1 leads to suppression of tumorigenic potential in human chondrosarcoma cells KARINA GALOIAN1, AMIR QURESHI1, GINA WIDEROFF1 and H.T. TEMPLE2 1Department of Orthopaedic Surgery; 2University of Miami Tissue Bank Division, Miller School of Medicine, University of Miami, Miami, FL 33136, USA Received September 18, 2014; Accepted October 8, 2014 DOI: 10.3892/mco.2014.445 Abstract. Disruption of cell-cell junctions and the concomi- and inhibits H3K9 demethylase activity, contributing to the tant loss of polarity, downregulation of tumor-suppressive suppression of tumorigenic potential in chondrosarcoma cells. adherens junctions and desmosomes represent hallmark phenotypes for several different cancer cells. Moreover, a Introduction variety of evidence supports the argument that these two common phenotypes of cancer cells directly contribute to Chondrosarcoma is a highly aggressive bone cancer of tumorigenesis. In this study, we aimed to determine the status mesenchymal origin, which is resistant to chemo- and radia- of intercellular junction proteins expression in JJ012 human tion therapies, leaving surgical resection as the only option. malignant chondrosarcoma cells and investigate the effect Metastatic spread of malignant cells eventually develops of the antitumorigenic cytokine, proline-rich polypeptide-1 following surgical resection. The malignant progression to (PRP-1) on their expression. The cell junction pathway array chondrosarcoma has been suggested to involve a degree of data indicated downregulation of desmosomal proteins, mesenchymal-to-epithelial transition (MET) and it has been such as desmoglein (1,428-fold), desmoplakin (620-fold) and demonstrated in an in vitro model that chondrosarcoma cells plakoglobin (442-fold).
    [Show full text]
  • Cytoskeletal Proteins in Neurological Disorders
    cells Review Much More Than a Scaffold: Cytoskeletal Proteins in Neurological Disorders Diana C. Muñoz-Lasso 1 , Carlos Romá-Mateo 2,3,4, Federico V. Pallardó 2,3,4 and Pilar Gonzalez-Cabo 2,3,4,* 1 Department of Oncogenomics, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands; [email protected] 2 Department of Physiology, Faculty of Medicine and Dentistry. University of Valencia-INCLIVA, 46010 Valencia, Spain; [email protected] (C.R.-M.); [email protected] (F.V.P.) 3 CIBER de Enfermedades Raras (CIBERER), 46010 Valencia, Spain 4 Associated Unit for Rare Diseases INCLIVA-CIPF, 46010 Valencia, Spain * Correspondence: [email protected]; Tel.: +34-963-395-036 Received: 10 December 2019; Accepted: 29 January 2020; Published: 4 February 2020 Abstract: Recent observations related to the structure of the cytoskeleton in neurons and novel cytoskeletal abnormalities involved in the pathophysiology of some neurological diseases are changing our view on the function of the cytoskeletal proteins in the nervous system. These efforts allow a better understanding of the molecular mechanisms underlying neurological diseases and allow us to see beyond our current knowledge for the development of new treatments. The neuronal cytoskeleton can be described as an organelle formed by the three-dimensional lattice of the three main families of filaments: actin filaments, microtubules, and neurofilaments. This organelle organizes well-defined structures within neurons (cell bodies and axons), which allow their proper development and function through life. Here, we will provide an overview of both the basic and novel concepts related to those cytoskeletal proteins, which are emerging as potential targets in the study of the pathophysiological mechanisms underlying neurological disorders.
    [Show full text]
  • Small Cell Lung Cancer Young Kwang Chae1,2, Wooyoung M
    www.nature.com/scientificreports OPEN Overexpression of adhesion molecules and barrier molecules is associated with diferential Received: 21 September 2017 Accepted: 12 December 2017 infltration of immune cells in non- Published: xx xx xxxx small cell lung cancer Young Kwang Chae1,2, Wooyoung M. Choi2, William H. Bae2, Jonathan Anker2, Andrew A. Davis2, Sarita Agte1, Wade T. Iams2, Marcelo Cruz2, Maria Matsangou1,2 & Francis J. Giles1,2 Immunotherapy is emerging as a promising option for lung cancer treatment. Various endothelial adhesion molecules, such as integrin and selectin, as well as various cellular barrier molecules such as desmosome and tight junctions, regulate T-cell infltration in the tumor microenvironment. However, little is known regarding how these molecules afect immune cells in patients with lung cancer. We demonstrated for the frst time that overexpression of endothelial adhesion molecules and cellular barrier molecule genes was linked to diferential infltration of particular immune cells in non-small cell lung cancer. Overexpression of endothelial adhesion molecule genes is associated with signifcantly lower infltration of activated CD4 and CD8 T-cells, but higher infltration of activated B-cells and regulatory T-cells. In contrast, overexpression of desmosome genes was correlated with signifcantly higher infltration of activated CD4 and CD8 T-cells, but lower infltration of activated B-cells and regulatory T-cells in lung adenocarcinoma. This inverse relation of immune cells aligns with previous studies of tumor-infltrating B-cells inhibiting T-cell activation. Although overexpression of endothelial adhesion molecule or cellular barrier molecule genes alone was not predictive of overall survival in our sample, these genetic signatures may serve as biomarkers of immune exclusion, or resistance to T-cell mediated immunotherapy.
    [Show full text]
  • Intermediate Filaments and Their Associated Proteins
    93 Intermediate ®laments and their associated proteins: multiple dynamic personalities Megan K Houseweart∗ and Don W Cleveland² A fusion of mouse and human genetics has now proven that regulated by phosphorylation, the recent identi®cation of intermediate ®laments form a ¯exible scaffold essential for several kinases involved strengthens the argument that structuring cytoplasm in a variety of cell contexts. In some these dynamics are true in vivo events. The growing cases, the formation of this scaffold is achieved through a list of intermediate-®lament-associated proteins (IFAPs) newly identi®ed family of intermediate-®lament-associated surely expands the repertoire of possible interactions proteins that form cross-bridges between intermediate permitted to IFs and may also add another layer of ®laments and other cytoskeletal elements, including actin and regulatory complexity. Indeed, the discovery of several microtubules. human and mouse diseases caused by mutations in the IFAP proteins plectin and neuronal bullous pemphigoid antigen (BPAG1n) illustrates the importance of these Addresses molecules in providing links between components of the ∗Ludwig Institute for Cancer Research and Division of Cellular and Molecular Medicine, University of California at San Diego, 9500 cellular cytoskeleton. Most would agree that intermediate Gilman Drive, La Jolla, CA 92093, USA ®laments can no longer be thought of as the least dynamic ²Ludwig Institute for Cancer Research, Division of Cellular and components of the cell cytoskeleton. This review
    [Show full text]